Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Mahave · SciRah

Researcher profile · Semantic Scholar

M. Mahave

Share profile

M. Mahave — researcher profile on SciRah

h-index: 15
Works: 41
Citations: 2,007

Most-cited papers

Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma.
T. Choueiri, P. Tomczak, S. Park, B. Venugopal +29 more
2021New England Journal of Medicine608 citations Open access
Semantic Scholar
Five-Year Survival Outcomes With Nivolumab Plus Ipilimumab Versus Chemotherapy as First-Line Treatment for Metastatic Non–Small-Cell Lung Cancer in CheckMate 227
J. Brahmer, Jong-Seok Lee, T. Ciuleanu, R. Bernabé Caro +20 more
2022Journal of Clinical Oncology340 citations Open access
Semantic Scholar
Overall Survival with Adjuvant Pembrolizumab in Renal-Cell Carcinoma.
T. Choueiri, P. Tomczak, Se Hoon Park, B. Venugopal +29 more
2024New England Journal of Medicine269 citations Open access
Semantic Scholar
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
T. Powles, P. Tomczak, S. Park, B. Venugopal +17 more
2022The Lancet Oncology229 citations Open access
Semantic Scholar
Immunotherapy in NSCLC: A Promising and Revolutionary Weapon.
C. Rolfo, C. Caglevic, M. Santarpia, A. Araújo +4 more
2017Advances in Experimental Medicine and Biology122 citations
Semantic Scholar
Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial
M. Balcells, Luis Rojas, N. Le Corre, C. Martínez-Valdebenito +28 more
2021PLoS Medicine74 citations Open access
Semantic Scholar
Systemic and intracranial outcomes with first-line nivolumab plus ipilimumab in patients with metastatic non-small cell lung cancer and baseline brain metastases from CheckMate 227 Part 1.
M. Reck, T. Ciuleanu, Jong-Seok Lee, M. Schenker +23 more
2023Journal of Thoracic Oncology64 citations Open access
Semantic Scholar
The Armed Conflict and the Impact on Patients With Cancer in Ukraine: Urgent Considerations
C. Caglevic, C. Rolfo, I. Gil-Bazo, A. Cardona +25 more
2022JCO Global Oncology37 citations Open access
Semantic Scholar
Pembrolizumab in HER2+ Gastric Cancer
Y. Janjigian, A. Kawazoe, Yu-Xian Bai, Jian-Ming Xu +22 more
2024New England Journal of Medicine35 citations Open access
Semantic Scholar
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for patients with renal cell carcinoma: Randomized, double-blind, phase III KEYNOTE-564 study.
T. Choueiri, P. Tomczak, S. Park, B. Venugopal +16 more
2021Journal of Clinical Oncology35 citations
Semantic Scholar
Early Anti-SARS-CoV-2 Convalescent Plasma in Patients Admitted for COVID-19: A Randomized Phase II Clinical Trial
M. Balcells, Luis Rojas, N. Le Corre, C. Martínez-Valdebenito +28 more
2020medRxiv28 citations Open access
Semantic Scholar
Overall survival results from the phase 3 KEYNOTE-564 study of adjuvant pembrolizumab versus placebo for the treatment of clear cell renal cell carcinoma (ccRCC).
T. Choueiri, P. Tomczak, Se Hoon Park, B. Venugopal +16 more
2024Journal of Clinical Oncology25 citations
Semantic Scholar
Patient-Reported Outcomes in KEYNOTE-564: Adjuvant Pembrolizumab Versus Placebo for Renal Cell Carcinoma
T. Choueiri, P. Tomczak, S. Park, B. Venugopal +17 more
2023The Oncologist25 citations Open access
Semantic Scholar
Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma: Results from 30-month follow-up of KEYNOTE-564.
T. Choueiri, P. Tomczak, S. Park, B. Venugopal +16 more
2022Journal of Clinical Oncology22 citations
Semantic Scholar
Total neoadjuvant chemotherapy with FLOT scheme in resectable adenocarcinoma of the gastro-oesophageal junction or gastric adenocarcinoma: impact on pathological complete response and safety
L. Villanueva, Jaime Anabalón, J. M. Butte, P. Salman +13 more
2021ecancermedicalscience21 citations Open access
Semantic Scholar
Triple-negative breast cancer: the reality in Chile and in Latin America
C. Caglevic, Jaime Anabalón, C. Soza, Elizabeth Milla +5 more
2019ecancermedicalscience14 citations Open access
Semantic Scholar
Seroconversion and Abundance of IgG Antibodies against S1-RBD of SARS-CoV-2 and Neutralizing Activity in the Chilean Population
R. González-Stegmaier, K. Cereceda, J. Briones, C. Beltrán-Pavez +13 more
2021Journal of Immunological Research12 citations Open access
Semantic Scholar
Evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer
P. Salman, S. Panay, R. Fernández, M. Mahave +1 more
2018OncoTargets and Therapy12 citations Open access
Semantic Scholar
The current situation for gastric cancer in Chile
C. Caglevic, Shirley Silva, M. Mahave, C. Rolfo +1 more
2016ecancermedicalscience9 citations Open access
Semantic Scholar
Convalescent Plasma in COVID-19; Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial
R. Gazitúa, J. Briones, C. Selman, F. Villarroel-Espíndola +28 more
20218 citations
Semantic Scholar
Adjuvant pembrolizumab (pembro) for renal cell carcinoma (RCC) across UCLA Integrated Staging System (UISS) risk groups and disease stage: Subgroup analyses from the KEYNOTE-564 study.
T. Choueiri, P. Tomczak, S. Park, B. Venugopal +16 more
2023Journal of Clinical Oncology7 citations
Semantic Scholar
Convalescent Plasma in COVID-19. Mortality-Safety First Results of the Prospective Multicenter FALP 001-2020 Trial
R. Gazitúa, J. Briones, C. Selman, F. Villarroel-Espíndola +27 more
2020medRxiv5 citations Open access
Semantic Scholar
653O Pembrolizumab (pembro) vs placebo as adjuvant therapy for patients (pts) with renal cell carcinoma (RCC): Patient-reported outcomes (PRO) in KEYNOTE-564
T. Choueiri, P. Tomczak, S. Park, B. Venugopal +16 more
2021Annals of Oncology4 citations Open access
Semantic Scholar
Mutational Landscape and Actionable Target Rates on Advanced Stage Refractory Cancer Patients: A Multicenter Chilean Experience
M. Córdova-Delgado, Mauricio P. Pinto, C. Regonesi, Luis Cereceda +14 more
2022Journal of Personalized Medicine3 citations Open access
Semantic Scholar
Is Neoadjuvant an Option for the Treatment of Non Metastatic Pancreatic Cancer Patients
C. Caglevic, S. Panay, C. FelipeReyes, C. Rolfo +1 more
20173 citations
Semantic Scholar
Hepatocellular carcinoma in identical twins in Chile: case report
C. Caglevic, Shirley Silva, M. Mahave, Javiera Torres +3 more
2016ecancermedicalscience3 citations Open access
Semantic Scholar
Current Systemic Treatment Options for Metastatic and Unresectable Pancreatic Cancer
C. Caglevic, M. Mahave, C. Sanhueza, L. Ubillos
2020Pancreatic Cancer [Working Title]2 citations Open access
Semantic Scholar
PLLBA-01 PEMBROLIZUMAB (PEMBRO) VS PLACEBO AS POST NEPHRECTOMY ADJUVANT THERAPY FOR PATIENTS (pts) WITH RENAL CELL CARCINOMA (RCC): RANDOMIZED, DOUBLE-BLIND, PHASE 3 KEYNOTE-564 STUDY
T. Choueiri, P. Tomczak, S. Park, B. Venugopal +16 more
20211 citations Open access
Semantic Scholar
Neoadjuvant treatment in non- metastatic pancreatic cancer, an option to be considered
C. Caglevic, S. Panay, F. Reyes C., C. Rolfo +1 more
2018Gastroenterology & Hepatology: Open Access1 citations Open access
Semantic Scholar
Improving Gallbladder Cancer Outcomes with Antibody-Based Therapies and Immunological Profiling: A Literature Review
C. Caglevic, Mario Alex Contreras-Torrez, Felipe Reyes-Cosmelli, Rodrigo Uribe-Maturana +6 more
2026Antibodies0 citations Open access
Semantic Scholar
Total neoadjuvant chemotherapy with FLOT for resectable gastric and gastroesophageal junction adenocarcinoma: Real-world outcomes from a Chilean oncology institution.
L. Villanueva, S. Hoefler, M. Callahan, A. Caro +14 more
2026Journal of Clinical Oncology0 citations
Semantic Scholar
Abstract P3-08-08: Clinical and financial impact of implementation of Oncotype Dx in women with HR positive HER2 negative early breast cancer treated in a Chilean Cancer Center
R. Allende, I. Saffie, M. Canals, Catalina Gonzalez +7 more
2025Clinical Cancer Research0 citations
Semantic Scholar
ADJUVANT PEMBROLIZUMAB FOR RENAL CELL CARCINOMA (KEYNOTE-564): EXPLORATORY ANALYSIS ACROSS UCLA INTEGRATED STAGING SYSTEM RISK GROUPS AND DISEASE STAGE
Tian Zhang, T. Choueiri, P. Tomczak, Se Hoon Park +16 more
2024Urologic oncology: Seminars and original investigations0 citations
Semantic Scholar
[Recommendations about the Programming of Medical Activities in Medical Oncology of the Chilean Society of Medical Oncology].
Elizabeth Milla, Rodrigo Bertin, Jorge Madrid, L. Villanueva +4 more
2023Revista médica de Chile (Impresa)0 citations Open access
Semantic Scholar
Late‐breaking Oral Abstract Session
C. Selman, J. Briones, Franz Villarroel, C. Caglevic +35 more
2020Transfusion0 citations
Semantic Scholar
Results of a Chilean Nation-Wide Network of Blood Banks for Convalescent Plasma Collection for Pandemic SARS-CoV-2 Treatment
C. Selman, J. Briones, Franz Villarroel, C. Caglevic +31 more
20200 citations
Semantic Scholar
A Strategy for SARS-CoV-2 Convalescent Plasma Collection in a Chilean Nation-Wide Blood Bank Network
C. Selman, J. Briones, F. Sánchez, Silvia Díaz +31 more
20200 citations
Semantic Scholar
A chilean blood bank network for COVID-19 convalescent plasma apheresis
J. Briones, C. Selman, Franz Villarroel, C. Caglevic +31 more
20200 citations
Semantic Scholar
Complete preoperative chemotherapy regimen FLOT: Evaluating the safety and histopathologic results in gastric cancer (GC).
L. Villanueva, Jaime Anabalón, O. Barajas, C. Gallardo +14 more
20180 citations
Semantic Scholar
evidence of response to pembrolizumab in a patient with Lynch syndrome-related metastatic colon cancer
P. Salman, S. Panay, R. Fernández, M. Mahave +1 more
20180 citations
Semantic Scholar
Checkpoints inhibitors in first line therapy of metastatic non-small cell lung cancer patients
L. Raez, C. Rolfo, M. Mahave, C. Caglevic
20160 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

C. Caglevic×21
Invite
C. Caglevic — researcher profile on SciRah
J. Hajek×11
Invite
J. Hajek — researcher profile on SciRah
N. Sarwar×11
Invite
N. Sarwar — researcher profile on SciRah
M. Gross-Goupil×11
Invite
M. Gross-Goupil — researcher profile on SciRah

×11

Invite

P. Sawrycki — researcher profile on SciRah

Invite

T. Powles — researcher profile on SciRah

Invite

C. Selman — researcher profile on SciRah

B. Venugopal×9

Invite

B. Venugopal — researcher profile on SciRah

S. Symeonides×9

Invite

S. Symeonides — researcher profile on SciRah

A. Thiery-Vuillemin×9

Invite

A. Thiery-Vuillemin — researcher profile on SciRah

Invite

R. Gazitúa — researcher profile on SciRah

Invite

J. Briones — researcher profile on SciRah